Background Bullous pemphigoid (BP) is the most common autoimmune blistering skin
disease worldwide. Systemic corticosteroids are considered the mainstay of therapy; …

Epidermolysis bullosa acquisita is a rare autoimmune disease, characterized by the
synthesis of anti-collagen VII autoantibodies, the main component of hemidesmosome …

Background Bullous pemphigoid commonly affects older adults and has a detrimental effect
on both quality of life and longevity. Systemic corticosteroids, the mainstay of therapy, may …

Background Bullous pemphigoid (BP) is the most common autoimmune subepidermal
bullous disease. Topical or systemic corticosteroids are often used as the first-line treatment …

Background Little data are available concerning the outcome of rituximab (RTX) therapy in
pediatric patients with autoimmune bullous diseases (AIBDs). Objective We sought to …

Background Multiple sclerosis (MS) as an autoimmune disorder is a common disease
occurring in central nervous system (CNS) and the remyelination plays a pivotal role in the …

We conducted a comprehensive series of molecular biological studies aimed at unraveling
the intricate mechanisms underlying the anti-fibrotic effects of triamcinolone acetonide (TA) …

Elderly patients are more susceptible to the development of autoimmune blistering disorders
such as bullous pemphigoid, mucous membrane pemphigoid, epidermolysis bullosa …

Pemphigus vulgaris localized to the tongue - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Management of bullous pemphigoid (BP) consists of general skin care measures as well as
pharmacologic therapy and is aimed at attenuating autoantibody inflammation to promote …